2002
DOI: 10.1016/s0140-6736(02)12021-6
|View full text |Cite
|
Sign up to set email alerts
|

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
122
1
5

Year Published

2004
2004
2016
2016

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 131 publications
(137 citation statements)
references
References 23 publications
9
122
1
5
Order By: Relevance
“…41 African countries with high pre-existing levels of SP resistance have achieved poor cure rates using AS-SP. 42,43 Although AS-SP was shown to be highly efficacious at the start of ACT roll out, 16 the high pre-existing dhfr triple mutation prevalence at the time of AS-SP implementation, together with the rather sharp increase in both the dhps double and "quintuple" mutations following ACT implementation, is cause for concern. Allen and colleagues 16 showed the presence of the "quintuple" mutation resulted in a 3-fold increased risk of treatment failure in Maputo Province, after adjusting for treatment arm, age, and temperature.…”
Section: Discussionmentioning
confidence: 99%
“…41 African countries with high pre-existing levels of SP resistance have achieved poor cure rates using AS-SP. 42,43 Although AS-SP was shown to be highly efficacious at the start of ACT roll out, 16 the high pre-existing dhfr triple mutation prevalence at the time of AS-SP implementation, together with the rather sharp increase in both the dhps double and "quintuple" mutations following ACT implementation, is cause for concern. Allen and colleagues 16 showed the presence of the "quintuple" mutation resulted in a 3-fold increased risk of treatment failure in Maputo Province, after adjusting for treatment arm, age, and temperature.…”
Section: Discussionmentioning
confidence: 99%
“…In Uganda, sensitivity rates of P falciparum to sulphadoxine-pyrimethamine range between 80% and 99%, 25 although failure rates were higher when recrudescence during 42 days of follow-up was evaluated. 29 Assessment of whether sulphadoxinepyrimethamine remains an effective treatment for individuals receiving co-trimoxazole prophylaxis 30 and whether its use increases sulphadoxine-pyrimethamine resistance in the broader community will be important. 31 Compliance with co-trimoxazole treatment was excellent and, as in other studies in Africa, 3,4,6 the treatment was very well tolerated.…”
Section: Discussionmentioning
confidence: 99%
“…The details of these studies have been previously published. [6][7][8] These samples were selected randomly for our study after stratifying based on parasite density, which was determined by thick smear.…”
Section: Methodsmentioning
confidence: 99%